Holen Sie sich die Stockscreener-App
83.98
0.57%
0.48
Handel nachbörslich:
83.98
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt EW?
Forum
Prognose
Aktiensplit
Edwards Lifesciences Corp Aktie (EW) Neueste Nachrichten
Exencial Wealth Advisors LLC Trims Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Barclays Lifts PT on Edwards Lifesciences Corporation (EW) Following Q1 Earnings - Yahoo Finance
Edwards Lifesciences Corp. stock outperforms competitors on strong trading day - MarketWatch
Jennison Associates LLC Sells 178,259 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
How The Edwards Lifesciences (EW) Investment Story Is Shifting As Views On Growth Diverge - Yahoo Finance
Edwards Lifesciences Corp. Experiences Valuation Adjustment Amid Competitive Market Landscape - Markets Mojo
Vanguard (NYSE: EW) reports 43.48M shares, 7.54% stake in Edwards Lifesciences - Stock Titan
Edwards Lifesciences Corp. stock outperforms competitors despite losses on the day - MarketWatch
Mitsubishi UFJ Trust & Banking Corp Cuts Stake in Edwards Lifesciences Corporation $EW - MarketBeat
Edwards Lifesciences Corporation (NYSE:EW) Receives Average Recommendation of "Moderate Buy" from Brokerages - MarketBeat
Edwards Lifesciences Corp. stock underperforms Tuesday when compared to competitors - MarketWatch
Edwards CEO speaks May 12, with live webcast and same-day replay - Stock Titan
AMG National Trust Bank Takes Position in Edwards Lifesciences Corporation $EW - MarketBeat
EW Technical Analysis | Trend, Signals & Chart Patterns | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Vanguard Group Inc. Sells 283,775 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
MDEV volume surges 14x as Edwards Lifesciences jumps - TipRanks
US28176EAD04 Bond Analysis — Key Metrics - TradingView
Munich Reinsurance Co Stock Corp in Munich Purchases 52,494 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
A Look at Edwards Lifesciences Corp (EW) After 5.6% Gain -- GF V - GuruFocus
Edwards Lifesciences Stock Surges On Heart Valve Devices Growth - Benzinga
Edwards raises 2026 guidance on strong TAVR performance - BioWorld News
Edwards Lifesciences jumps 5.2% as Q1 results top expectations and full-year guidance rises - Quiver Quantitative
Edwards Lifesciences raises FY26 guidance following strong Q1 - Yahoo Finance
TD Cowen reiterates Edwards Lifesciences stock Buy rating on strong Q1 results - Investing.com
Bernstein SocGen raises Edwards Lifesciences stock price target to $96 - Investing.com
Stifel reiterates Edwards Lifesciences stock rating on strong Q1 beat - Investing.com
Stifel reiterates Edwards Lifesciences stock rating on strong Q1 beat By Investing.com - Investing.com Canada
Edwards Lifesciences (NYSE:EW) Given New $87.00 Price Target at Robert W. Baird - MarketBeat
Edwards Lifesciences (NYSE:EW) Price Target Raised to $100.00 at BTIG Research - MarketBeat
OLD National Bancorp IN Sells 16,066 Shares of Edwards Lifesciences Corporation $EW - MarketBeat
Bernstein Adjusts PT on Edwards Lifesciences to $96 From $95, Maintains Market Perform Rating - marketscreener.com
Teacher Retirement System of Texas Has $23.75 Million Holdings in Edwards Lifesciences Corporation $EW - MarketBeat
Canaccord Genuity Adjusts PT on Edwards Lifesciences to $85 From $87, Maintains Hold Rating - marketscreener.com
Barclays Adjusts PT on Edwards Lifesciences to $110 From $104, Maintains Overweight Rating - marketscreener.com
Baird Adjusts Price Target on Edwards Lifesciences to $87 From $85, Maintains Neutral Rating - marketscreener.com
Goldman Sachs Adjusts Price Target on Edwards Lifesciences to $98 From $97, Maintains Buy Rating - marketscreener.com
BTIG raises Edwards Lifesciences stock price target on strong Q1 beat - Investing.com Australia
BTIG raises Edwards Lifesciences stock price target on strong Q1 beat By Investing.com - Investing.com South Africa
Truist raises Edwards Lifesciences stock price target on TAVR growth - Investing.com
Barclays raises Edwards Lifesciences stock price target on EBITDA outlook - Investing.com
Truist raises Edwards Lifesciences stock price target on TAVR growth By Investing.com - Investing.com Canada
EW Stock Price, Quote & Chart | EDWARDS LIFESCIENCES CORP (NYSE:EW) - ChartMill
Edwards Lifesciences Corp (EW) Q1 2026 Earnings Call Highlights: - GuruFocus
Edwards Lifesciences Q1 Earnings Call Highlights - MarketBeat
Edwards Lifesciences reports Q1 EPS 78c, consensus 73c - TipRanks
Earnings call transcript: Edwards Lifesciences Q1 2026 beats expectations By Investing.com - Investing.com South Africa
Is Edwards Lifesciences (EW) Still 13.6% Undervalued After Q1 20 - GuruFocus
Earnings call transcript: Edwards Lifesciences Q1 2026 beats expectations - Investing.com
Transcript: Edwards Lifesciences Q1 2026 Earnings Conference Call - Benzinga
Compared to Estimates, Edwards Lifesciences (EW) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Edwards Lifesciences (EW) Raises FY26 Sales Growth Guidance - GuruFocus
Edwards Lifesciences Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Q1 2026 Edwards Lifesciences Corp Earnings Call Transcript - GuruFocus
Edwards Lifesciences (NYSE:EW) Releases Q2 2026 Earnings Guidance - MarketBeat
Edwards Lifesciences Corp. stock underperforms Thursday when compared to competitors - MarketWatch
Edwards Lifesciences options imply 5.2% move in share price post-earnings - TipRanks
Edwards Lifesciences (EW) Stock Rises on Q1 2026 Earnings - Quiver Quantitative
Edwards Lifesciences shares rise 4% as guidance raised following Q1 earnings beat - Investing.com Canada
Edwards Lifesciences shares rise 4% as guidance raised following Q1 earnings beat By Investing.com - Investing.com India
Edwards Lifesciences Q1 Earnings, Revenue Rise - marketscreener.com
Edwards Lifesciences (NYSE:EW) Releases Earnings Results, Beats Estimates By $0.05 EPS - MarketBeat
Edwards Lifesciences reports Q1 revenue $1.65B, raises 2026 sales and adjusted EPS guidance - TradingView
Stronger Q1 boosts 2026 outlook for Edwards Lifesciences (NYSE: EW) - Stock Titan
0.31%
0.68%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):